The company's three series of drugs: bio-fermentation raw materials, synthetic r
The two main products in the chemical synthetic raw material production workshop
The two main products in the chemical synthetic raw material production workshop
The two main products in the chemical synthetic raw material production workshop
Our company is the first batch of raw material manufacturer of diclofenac sodium
Our company's small-capacity injection workshop invested 39 million yuan, and in
Lidocaine Hydrochloride Injection
Specification: 5ml: 0.1g
National medicine standard word H41023058
Specification: 10ml: 0.5g
National medicine standard word H41023047
Specification: 2ml: 0.5g
National medicine standard word H20045773
Specification: 2ml: 0.1g
National medicine standard word H41023030
Specification: 10ml: 2.5g
National medicine standard word H41023035
Specification: 10ml: 1g
National medicine standard word H41023479
Specification: 20ml: 10g
National medicine standard word H41023044
Shanghai Jin Emperor (Anyang) Co., Ltd.
Shanghai Jindi Kyushu Pharmaceutical (Anyang) Co., Ltd.
Switchboard: 0372--6250880 Fax: 0372--6250890
E-mail: jz6250890@126.com
Website: www.undertheinkfluence.com
Marketing Center: 0372--6250892
Sales of APIs:
Mr. Fu: 135-6903-7762 (Foreign Ministry)
Mr. Chen: 134-0372-0000
Mr. Ye: 139-4953-3698
Miss Du：185-6885-8530
Injection sales:
Mr. An: 151-3101-5755
Supply Department:
Mr. Wang: 138-3721-3711
Mr. Zhao: 136-6372-8999
Mr. Niu: 139-4952-8999
Human Resources Recruitment: Ms. Song: 155-1878-5470
Company Address: Tangyin Road, Tangyin Industrial Cluster, Anyang City, Henan Province
Company zip code: 456150
Care for the Kyushu cause, look at the world market
Many times, when we do something, what we often lack is not knowledge and ability, but the mind, vision and realm. Take our warehouse clerk, although the position is not ordinary,
Strict quality control to ensure product quality
Quality is the life of an enterprise. We always put quality first. Without quality, companies have no way to survive.
Kyushu Briefing Issue 170
The development and growth of the enterprise is made up of countless entrepreneurial history. The footprints of Jindi Kyushu people's hard work, one by one, they are struggling to
Kyushu Briefing Issue 169
On February 10th, Tangyin County held the 2017 “Five Winds” Construction Work Commendation Conference at the Radio and Television Broadcasting Center. Zhao Wenwu, the chairman of o
Now our company has strong technical force, advanced process equipment, complete testing means and broad sales network. After the existing workshops are put into production, it is estimated that the annual sales income will be 350 million yuan and the profit and tax will be 30 million yuan. In order to adjust the product structure, increase new economic growth points, and promote enterprises to become stronger and stronger, the shareholders will decide to introduce funds in various forms and intend to carry out various forms of cooperation with large pharmaceutical enterprise groups. Ways and means can be specifically negotiated, such as capital increase and share expansion, holding, acquisition of shares and debt-to-equity swaps, or investors can bring funds, bring projects, and adopt fixed-reward cooperation methods. Companies rely on various resource advantages, is willing to cooperate with well-known medical research institutions and pharmaceutical manufacturers. Chairman of the company Zhao Wenwu, general manager Zhang Lixia and all shareholders, warmly welcome domestic and foreign knowledgeable and ambitious people to come to our company to invest in the industry and seek common development!
